Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07800455 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Amygdala-Prefrontal in Fear Extinction

StatusRecruiting
PhaseNot applicable
Started2026-09-15
View on ClinicalTrials.gov ↗
The goal of this clinical trial is to understand how brain circuits involving the amygdala and prefrontal cortex contribute to fear learning and extinction. Fear extinction is the process by which a fear response decreases when a threat is no longer present. The study will include participants with epilepsy who are undergoing stereoelectroencephalography (SEEG) monitoring as part of their clinical care. The main questions this study aims to answer are: How do the amygdala and prefrontal cortex interact during fear learning and extinction? Do different parts and hemispheres of the amygdala have different roles in fear learning and extinction? How does electrical stimulation of the amygdala affect these brain circuits and fear extinction? Participants will complete tasks involving fear learning and extinction while researchers record brain activity from clinically implanted electrodes. Researchers will also use electrical stimulation via these electrodes to study how amygdala activity affects other brain regions and fear extinction.
Trial Details
NCT Number NCT07800455
Lead Sponsor Washington University School of Medicine
Collaborators: National Institute of Mental Health (NIMH)
Conditions Fear Extinction
Enrollment 40 participants
Start Date 2026-09-15
Primary Completion 2031-07-31 (estimated)
Study Completion 2032-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-09-02